期刊文献+

恶性肿瘤现代微创或无创治疗的临床工作准则

Clinical Practice Guideline of Modern Microinvasive or Noninvasive Treatment for Malignant Tumours
下载PDF
导出
摘要 目的 探讨恶性肿瘤现代微创或无创治疗的临床工作准则。方法 分析目前恶性肿瘤临床治疗的8种微创或无创治疗 (X 刀、γ 刀、粒子刀、中子刀、微波集束聚能刀、高能射频集束刀、超声聚焦刀、氩氦刀 )的基本特性与临床特征 ,结合临床经验及文献资料进行讨论。结果 ①恶性肿瘤现代微创或无创治疗技术可分为 3类 ,即射线束的毁损效应、高温消融效应、超低温冷冻消融效应。②具有对局部肿瘤能量高度集中、能量强度高的特点。③高能量集聚效应可高效性原位灭活或局部根治肿瘤 ,对人体损伤小 ,适应证较宽。④主要适用于肿瘤体积在一定范围而且形态较规则的肿瘤。结论 恶性肿瘤现代微创或无创治疗方法具有高科技、高效性杀灭肿瘤的特点 ,是肿瘤局部治疗的重要手段之一 ,对外科手术治疗形成挑战。恶性肿瘤微创或无创治疗应把握好综合治疗的时机。 Objective To evaluate clinical practice guideline of modern microinvasive or noninvasive treatment in human malignant carcinoma. Methods Analyse and discussion the basic characteristics and clinical feature combined with clinic and document about microinvasive or noninvasive treatiment of eight kinds (stereotactic radiation therapy, seeds knife, neutron knife, focused microwave coagulation, radio frequancy thermed ablation, high intensity focused ultrasound, Ar He cryoablation surgery). Results ① These treatment methods may be classnified into three sorts effects: Radiation coagulations and thermal ablation and cryoablation. ② There are charcteristic of high energy collection effect for local tumour. ③ Not only carcinoma may be eradicated as effective as operation, but also they minimally injury to human. ④ It is mainly suited to tumour of proper size and regular shape. Conclusion Modern microinvasive or noninvasive treatment methords are one of local ablation therapy for malignant carcinoma. It is give rise to challenge for surgery. Combining therapy are necessary for advanced carcinoma.\;
出处 《海军总医院学报》 2003年第3期148-151,共4页 Journal of Naval General Hospital of PLA
关键词 恶性肿瘤 微创 无创 治疗 Malignant neoplasms Microinvasive Noninvasive Therapy
  • 相关文献

参考文献3

二级参考文献21

  • 1刘英华,王忠诚,石祥恩,张懋植.恶性胶质瘤施行嘧啶亚硝脲化学治疗临床观察[J].中华神经外科杂志,1997,13(1):28-30. 被引量:22
  • 2Sneed P, Mcdermott MW,Gutin P,etal. Interstitial brachytherapy procedures for brain tumors. Seminars in Surgical Oncology,1997,13:157-166.
  • 3Gaspar LE,Zamorano, LJ,Shamsa F,et al. Permanent125Iodine implants for recurrentmalignant gliomas. Int J Radait Oncol Bio Phys, 1999,43:977-982.
  • 4Halligan JB, Stelzer KJ, Rostomily RC et al. Operation and permanent lowactivity125I brachytherapy for recurrent high-grade astrocytomas.Int J Radait Oncol BioPhys,1996,35:541-547.
  • 5Vikram B. Permanent Iodine-125 boost after teletherapy in primary cancer of thenasopharynx is safe and highly effective :long-term results. Int J Radait oncol Bio Phys,1997,38:1140.
  • 6Matsumoto S, akeda M, Shibuya H, et a1. T1 and T2 squamous cell carcinomas of thefloor of the mouth: Results of brachytherapy mainly using198 Au grains. Int J Radait OncolBio Phys, 1996,34:833-841.
  • 7Chen A, Galloway M, Landreneau R, et al. Introperative 125 I brachytherap forhigh-risk stage I non-small cell lung carcinoma. Int J Radait Oncol Bio Phys,1999,44:1057-1063.
  • 8Peterz T, Nori D, Hilaris B, et al. Treatment of primary unresectable carcinoma ofthe pancreas with I-125 implantation. Int J Radait Oncol Bio Phys, 1989,17:931-935.
  • 9Martinez-Monge R,Nag S,Edward W,et al125 I brachytherapy for colorectaladenocarcinona recurrent in the pelvia and paraortics. Int J Radait oncol BioPhya,1998,42:545-500.
  • 10Storey MR,Landgren RC,Cottone JL, et al.Transperineal 12J Iodine im-plantation fortreatment of clinically localized prostate cancer:5-year tumor control and morbidity. IntJ Radait Oncol Bio Phys, 1999,43:565-570.

共引文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部